Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CV Sciences, Inc. (CVSI)
|
Add to portfolio |
|
|
|
| Price: |
$0.13
| | Metrics |
| OS: |
154.6
|
M
| |
|
|
| Market cap: |
$20.1
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$0.03
| |
5.16
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 20.0 | 24.4 | 53.7 | 48.2 | 20.7 | 11.1 | 11.5 | 10.2 |
| Revenue growth | -17.9% | -54.5% | 11.3% | 133.3% | 87.0% | -4.1% | 13.1% | 373.1% |
| Cost of goods sold | 11.4 | 13.4 | 18.6 | 14.4 | 6.2 | 4.1 | 4.8 | 4.4 |
| Gross profit | 8.6 | 11.0 | 35.1 | 33.9 | 14.5 | 7.0 | 6.7 | 5.8 |
| Gross margin | 43.0% | 45.1% | 65.3% | 70.2% | 70.1% | 63.3% | 58.4% | 57.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 1.2 | 2.9 | 5.9 | 1.9 | 0.7 | 1.2 | 1.3 | 1.0 |
| General and administrative | 25.9 | 30.7 | 46.5 | 21.7 | 16.2 | 13.1 | 17.4 | 13.4 |
| EBIT | -18.4 | -22.6 | -17.2 | 10.2 | -4.9 | -10.3 | -10.5 | -8.6 |
| EBIT margin | -92.0% | -92.5% | -32.1% | 21.2% | -23.5% | -93.4% | -90.7% | -83.9% |
| Pre-tax income | -15.6 | -22.6 | -17.2 | 10.1 | -5.4 | -14.1 | -12.2 | -1.3 |
| Income taxes | -0.1 | -0.3 | -0.6 | 0.1 | -0.5 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.6% | 1.4% | 3.6% | 0.9% | 9.0% | 0.0% | 0.0% | 0.0% |
| Net income | -15.6 | -22.3 | -16.6 | 10.0 | -4.9 | -14.1 | -12.2 | -1.3 |
| Net margin | -77.6% | -91.2% | -30.9% | 20.7% | -23.7% | -127.9% | -106.1% | -12.9% |
| |
| Diluted EPS | ($0.14) | ($0.22) | ($0.17) | $0.09 | ($0.06) | ($0.27) | ($0.35) | ($0.04) |
| Shares outstanding (diluted) | 107.8 | 99.9 | 97.9 | 114.5 | 80.4 | 52.7 | 35.1 | 31.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|